Industry: Service & Software
Published Date: 2026-03-12
Pages: 98 Pages
Report ld: 6250416
Request Sample
Customized Report
Urine Drug Testing Service Market Size(US$)

CAGR 2026-2032
4.6%
Market Size,2032
USD 2,946
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Urine Drug Testing Service market size was US$ 2157 million in 2025 and is forecast to reach a readjusted size of US$ 2946 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Urine Drug Testing Service refers to the process of analyzing a urine sample to detect the presence or absence of specific drugs or their metabolites, typically used for clinical, occupational, legal, or forensic purposes. This service is widely recognized as one of the most common and non-invasive drug testing methods due to its ease of sample collection, cost-effectiveness, and relatively long detection window for many substances. Urine drug testing can detect a wide range of substances, including cannabinoids, amphetamines, opioids, cocaine, benzodiazepines, and other prescription or illicit drugs. It is commonly employed in workplace drug screening programs, pre-employment checks, post-incident investigations, law enforcement, rehabilitation monitoring, and clinical diagnosis.
In 2025, the North America Urine Drug Testing Service market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Urine Drug Testing Service include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health, Keystone Laboratories, Crystal Health, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Urine Drug Testing Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Urine Drug Testing Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 On-site Testing
1.2.3 Laboratory-based Testing
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urine Drug Testing Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Urine Drug Testing Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Urine Drug Testing Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.2 Europe Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.3 China Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.4 Japan Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.5 Southeast Asia Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.6 India Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.7 South America Urine Drug Testing Service Market Size and Prospective (2021-2032)
2.5.8 Middle East Urine Drug Testing Service Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Urine Drug Testing Service Historical Market Size by Type (2021-2026)
3.2 Global Urine Drug Testing Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Urine Drug Testing Service
4 Breakdown Data by Application
4.1 Global Urine Drug Testing Service Historical Market Size by Application (2021-2026)
4.2 Global Urine Drug Testing Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Urine Drug Testing Service Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Urine Drug Testing Service Players by Revenue (2021-2026)
5.1.2 Global Urine Drug Testing Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Urine Drug Testing Service Revenue
5.4 Global Urine Drug Testing Service Market Concentration Analysis
5.4.1 Global Urine Drug Testing Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Urine Drug Testing Service Revenue in 2025
5.5 Global Key Players of Urine Drug Testing Service Head Offices and Areas Served
5.6 Global Key Players of Urine Drug Testing Service, Product and Application
5.7 Global Key Players of Urine Drug Testing Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Urine Drug Testing Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Urine Drug Testing Service Market Size by Type (2021-2026)
6.1.2.2 North America Urine Drug Testing Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Urine Drug Testing Service Market Size by Application (2021-2026)
6.1.3.2 North America Urine Drug Testing Service Market Share by Application (2021-2026)
6.1.4 North America Urine Drug Testing Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Urine Drug Testing Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Urine Drug Testing Service Market Size by Type (2021-2026)
6.2.2.2 Europe Urine Drug Testing Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Urine Drug Testing Service Market Size by Application (2021-2026)
6.2.3.2 Europe Urine Drug Testing Service Market Share by Application (2021-2026)
6.2.4 Europe Urine Drug Testing Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Urine Drug Testing Service Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Urine Drug Testing Service Market Size by Type (2021-2026)
6.3.2.2 China Urine Drug Testing Service Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Urine Drug Testing Service Market Size by Application (2021-2026)
6.3.3.2 China Urine Drug Testing Service Market Share by Application (2021-2026)
6.3.4 China Urine Drug Testing Service Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Urine Drug Testing Service Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Urine Drug Testing Service Market Size by Type (2021-2026)
6.4.2.2 Japan Urine Drug Testing Service Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Urine Drug Testing Service Market Size by Application (2021-2026)
6.4.3.2 Japan Urine Drug Testing Service Market Share by Application (2021-2026)
6.4.4 Japan Urine Drug Testing Service Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia Urine Drug Testing Service Revenue by Company (2021-2026)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Urine Drug Testing Service Market Size by Type (2021-2026)
6.5.2.2 Southeast Asia Urine Drug Testing Service Market Share by Type (2021-2026)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Urine Drug Testing Service Market Size by Application (2021-2026)
6.5.3.2 Southeast Asia Urine Drug Testing Service Market Share by Application (2021-2026)
6.5.4 Southeast Asia Urine Drug Testing Service Major Customers
6.5.5 Southeast Asia Market Trends and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Urine Drug Testing Service Revenue by Company (2021-2026)
6.6.2 India Market Size by Type
6.6.2.1 India Urine Drug Testing Service Market Size by Type (2021-2026)
6.6.2.2 India Urine Drug Testing Service Market Share by Type (2021-2026)
6.6.3 India Market Size by Application
6.6.3.1 India Urine Drug Testing Service Market Size by Application (2021-2026)
6.6.3.2 India Urine Drug Testing Service Market Share by Application (2021-2026)
6.6.4 India Urine Drug Testing Service Major Customers
6.6.5 India Market Trends and Opportunities
7 Key Player Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott Urine Drug Testing Service Introduction
7.1.4 Abbott Revenue in Urine Drug Testing Service Business (2021-2026)
7.1.5 Abbott Recent Development
7.2 Labcorp
7.2.1 Labcorp Company Details
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Urine Drug Testing Service Introduction
7.2.4 Labcorp Revenue in Urine Drug Testing Service Business (2021-2026)
7.2.5 Labcorp Recent Development
7.3 Quest Diagnostics
7.3.1 Quest Diagnostics Company Details
7.3.2 Quest Diagnostics Business Overview
7.3.3 Quest Diagnostics Urine Drug Testing Service Introduction
7.3.4 Quest Diagnostics Revenue in Urine Drug Testing Service Business (2021-2026)
7.3.5 Quest Diagnostics Recent Development
7.4 Millennium Health
7.4.1 Millennium Health Company Details
7.4.2 Millennium Health Business Overview
7.4.3 Millennium Health Urine Drug Testing Service Introduction
7.4.4 Millennium Health Revenue in Urine Drug Testing Service Business (2021-2026)
7.4.5 Millennium Health Recent Development
7.5 Genesis Reference Labs
7.5.1 Genesis Reference Labs Company Details
7.5.2 Genesis Reference Labs Business Overview
7.5.3 Genesis Reference Labs Urine Drug Testing Service Introduction
7.5.4 Genesis Reference Labs Revenue in Urine Drug Testing Service Business (2021-2026)
7.5.5 Genesis Reference Labs Recent Development
7.6 Concentra
7.6.1 Concentra Company Details
7.6.2 Concentra Business Overview
7.6.3 Concentra Urine Drug Testing Service Introduction
7.6.4 Concentra Revenue in Urine Drug Testing Service Business (2021-2026)
7.6.5 Concentra Recent Development
7.7 DISA
7.7.1 DISA Company Details
7.7.2 DISA Business Overview
7.7.3 DISA Urine Drug Testing Service Introduction
7.7.4 DISA Revenue in Urine Drug Testing Service Business (2021-2026)
7.7.5 DISA Recent Development
7.8 Medigold Health
7.8.1 Medigold Health Company Details
7.8.2 Medigold Health Business Overview
7.8.3 Medigold Health Urine Drug Testing Service Introduction
7.8.4 Medigold Health Revenue in Urine Drug Testing Service Business (2021-2026)
7.8.5 Medigold Health Recent Development
7.9 Keystone Laboratories
7.9.1 Keystone Laboratories Company Details
7.9.2 Keystone Laboratories Business Overview
7.9.3 Keystone Laboratories Urine Drug Testing Service Introduction
7.9.4 Keystone Laboratories Revenue in Urine Drug Testing Service Business (2021-2026)
7.9.5 Keystone Laboratories Recent Development
7.10 Crystal Health
7.10.1 Crystal Health Company Details
7.10.2 Crystal Health Business Overview
7.10.3 Crystal Health Urine Drug Testing Service Introduction
7.10.4 Crystal Health Revenue in Urine Drug Testing Service Business (2021-2026)
7.10.5 Crystal Health Recent Development
7.11 MedTox
7.11.1 MedTox Company Details
7.11.2 MedTox Business Overview
7.11.3 MedTox Urine Drug Testing Service Introduction
7.11.4 MedTox Revenue in Urine Drug Testing Service Business (2021-2026)
7.11.5 MedTox Recent Development
7.12 Australian Clinical Labs
7.12.1 Australian Clinical Labs Company Details
7.12.2 Australian Clinical Labs Business Overview
7.12.3 Australian Clinical Labs Urine Drug Testing Service Introduction
7.12.4 Australian Clinical Labs Revenue in Urine Drug Testing Service Business (2021-2026)
7.12.5 Australian Clinical Labs Recent Development
7.13 Dominion Diagnostics
7.13.1 Dominion Diagnostics Company Details
7.13.2 Dominion Diagnostics Business Overview
7.13.3 Dominion Diagnostics Urine Drug Testing Service Introduction
7.13.4 Dominion Diagnostics Revenue in Urine Drug Testing Service Business (2021-2026)
7.13.5 Dominion Diagnostics Recent Development
7.14 Matrix Diagnostics
7.14.1 Matrix Diagnostics Company Details
7.14.2 Matrix Diagnostics Business Overview
7.14.3 Matrix Diagnostics Urine Drug Testing Service Introduction
7.14.4 Matrix Diagnostics Revenue in Urine Drug Testing Service Business (2021-2026)
7.14.5 Matrix Diagnostics Recent Development
7.15 Dorevitch Pathology
7.15.1 Dorevitch Pathology Company Details
7.15.2 Dorevitch Pathology Business Overview
7.15.3 Dorevitch Pathology Urine Drug Testing Service Introduction
7.15.4 Dorevitch Pathology Revenue in Urine Drug Testing Service Business (2021-2026)
7.15.5 Dorevitch Pathology Recent Development
8 Urine Drug Testing Service Market Dynamics
8.1 Urine Drug Testing Service Industry Trends
8.2 Urine Drug Testing Service Market Drivers
8.3 Urine Drug Testing Service Market Challenges
8.4 Urine Drug Testing Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Urine Drug Testing Service market is projected to grow from US$ 2157 million in 2025 to US$ 2946 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 132
USD 4900.00
(Single User License)
The global Urine Drug Testing Service market was valued at US$ 2157 million in 2025 and is anticipated to reach US$ 2946 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 118
USD 2900.00
(Single User License)
The global market for Urine Drug Testing Service was estimated to be worth US$ 2157 million in 2025 and is projected to reach US$ 2946 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 112
USD 3950.00
(Single User License)
The global Urine Drug Testing Service market is projected to grow from US$ 2085 million in 2024 to US$ 2829 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-13
Pages: 136
USD 4900.00
(Single User License)
The global market for Urine Drug Testing Service was valued at US$ 2085 million in the year 2024 and is projected to reach a revised size of US$ 2829 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published Date: 2025-08-13
Pages: 87
USD 2900.00
(Single User License)
The global market for Urine Drug Testing Service was estimated to be worth US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 116
USD 3950.00
(Single User License)
The global Urine Drug Testing Service market size was US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 98
USD 4250.00
(Single User License)
The global Urine Drug Testing Service market is projected to grow from US$ 2157 million in 2025 to US$ 2946 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 132
The global Urine Drug Testing Service market was valued at US$ 2157 million in 2025 and is anticipated to reach US$ 2946 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 118
The global market for Urine Drug Testing Service was estimated to be worth US$ 2157 million in 2025 and is projected to reach US$ 2946 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 112
The global Urine Drug Testing Service market is projected to grow from US$ 2085 million in 2024 to US$ 2829 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-13
Pages: 136
The global market for Urine Drug Testing Service was valued at US$ 2085 million in the year 2024 and is projected to reach a revised size of US$ 2829 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-08-13
Pages: 87
The global market for Urine Drug Testing Service was estimated to be worth US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 116
The global Urine Drug Testing Service market size was US$ 2085 million in 2024 and is forecast to a readjusted size of US$ 2829 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 98
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now